Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

计划入组 10 人 · 首次发布于 2020 年 7 月 1 日

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

计划入组 20 人 · 首次发布于 2014 年 6 月 26 日

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version

计划入组 15 人 · 首次发布于 2015 年 2 月 3 日

APC-366

APC-002

APC-501

JIUYUAN GENE

Triple-Gene LLC

United States

MOMOTARO-GENE INC.

Japan

Recursion's REC-4881 Shows 30% Polyp Reduction in FAP Patients in Phase 1b/2 Trial

Short-Term Postoperative Outcomes Comparable Between IRA and IPAA in FAP, Cleveland Clinic Study Finds

Recursion's REC-4881 Shows Durable Polyp Reduction in Familial Adenomatous Polyposis Phase 2 Trial